ArticleHuman vaccines & immunotherapeutics2016
Hepatitis B-related knowledge and vaccination in association with discrimination against Hepatitis B in rural China.
Article in Human vaccines & immunotherapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed.
- Knowledge, attitudes, and practices toward hepatitis B virus infection among hepatitis-B patients in Qinghai Province, China.BMC public health · 2026Article
- Development and Validation of a Social Influence Scale for Antiviral Therapy Behavior of Patients with Chronic Hepatitis B.Risk management and healthcare policy · 2026Article
- Breaking the stigma: the role of family support in hepatitis B management from a public health education perspective.Frontiers in public health · 2026Review
- HBV Transmission Knowledge Among Korean-American Chronic Hepatitis B Patients in the United States.Journal of community health · 2025Article
- Article
- Racial discrimination, knowledge, and health outcomes: The mediating role of hepatitis B-related stigma among patients with chronic hepatitis B.Journal of viral hepatitis · 2024Article
- Health economic analysis and medical cost analysis of children with severe hepatitis B in China: A retrospective study from 2016 to 2022.Chinese medical journal · 2024Article
- Impact and Cost-Effectiveness of Biomedical Interventions on Adult Hepatitis B Elimination in China: A Mathematical Modelling Study.Journal of epidemiology and global health · 2023Article
- The influencing factors of discrimination against recovered Coronavirus disease 2019 (COVID-19) patients in China: a national study.Human vaccines & immunotherapeutics · 2022Article
- Hepatitis B, C and human immunodeficiency virus knowledge among the general greek population: results from the Hprolipsis nationwide survey.BMC public health · 2022Article
- Hepatitis B-related stigma among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study.Health & social care in the community · 2022Article
- Article
- Article
- Article
- Article
- Regional differences of hepatitis B discrimination in rural China.Human vaccines & immunotherapeutics · 2021Article
- Will COVID-19 Vaccinations End Discrimination against COVID-19 Patients in China? New Evidence on Recovered COVID-19 Patients.Vaccines · 2021Article
- Chronic hepatitis B: the demise of the 'inactive carrier' phase.Hepatology international · 2021Review
- Vaccination against Hepatitis B: A Scoping Review.Asian Pacific journal of cancer prevention : APJCP · 2020Article
- The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure.Viruses · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatitis B virus (HBV) remains a challenging public-health issue in China. Hepatitis B carriers and patients suffer not only physically but also experience strong discrimination and stigma. China's rural population is 629 million. Thus, there is a great need to understand the situation surrounding HBV-related discrimination in everyday life in rural China. We studied 6,538 participants (≥18 y old) from 42 villages across 7 provinces (districts). Many studies have addressed discrimination against those with human immunodeficiency virus (HIV) and hepatitis C virus (HCV). However, few studies have addressed HBV-related discrimination. We found that the fear of HBV infection, not lack of knowledge about it, predominantly leads to HBV-related discrimination (although limited knowledge is also a cause). Notably, receiving the HBV vaccination contributes to reduced discrimination. In addition, the existence of fewer misunderstandings about false HBV transmission routes plays a more important role in discrimination than does understanding of true HBV transmission routes. Therefore, to reduce HBV-related discrimination, policy makers should consider eliminating HBV-related fear, strengthening adult HBV immunization programs, developing large-scale education dissemination about HBV transmission routes and non-transmission routes, and paying greater attention to target populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.